CRISPR Therapeutics AG (CRSP) is rated Buy, with a 12-month price target of $64.58, driven by CASGEVY's commercial ramp and a ...

For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.

Iru, the IT-security company that rebranded from Kandji last year, is taking nearly 92,000 square feet of office space at the ...

This device feels designed around a simple goal: letting professionals focus on their work, not their hardware.

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

The data did not meet investor expectations, and could bring “fierce investor debate on commercial feasibility,” according to ...

PM Modi struck a note of caution and resilience, describing the current geopolitical climate of US-Iran war, as ‘undoubtedly ...

India’s auto sector faces supply disruptions and slower growth in FY2027, with Crisil cutting forecasts as demand weakens ...

Wintrust Q4 2025 earnings show strong loan/deposit growth and top-tier NIM, but macro risks cap upside. See why I rate WTFC stock a Hold.

The former Chelsea captain has a playing CV few can match but his past controversies are not helping his bid to forge a ...

The business, started in 2024, was set up with an estimated initial capital of around Sh200,000. Rather than building a large ...

Despite the danger of sea mines, experts say that mine clearing has received minimal attention and funding from the U.S. Navy ...